Treatment of Hemophilia A with a Highly Purified Factor VIII Concentrate Prepared by Anti-FVIIIc Immunoaffinity Chromatography

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1970 • 253,849 citations

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

1979 • 54,907 citations

Continuous cultures of fused cells secreting antibody of predefined specificity

1975 • 17,037 citations

A simplified method for cyanogen bromide activation of agarose for affinity chromatography

1974 • 1,951 citations

Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

1953 • 748 citations

[Changes under the influence of high pressure of certain properties of myosin, actomyosin and actin].

1960 • 499 citations

Impaired Cell-Mediated Immunity in Patients with Classic Hemophilia

1983 • 338 citations

ISOLATION OF NEW LYMPHOTROPIC RETROVIRUS FROM TWO SIBLINGS WITH HAEMOPHILIA B, ONE WITH AIDS

1984 • 251 citations

Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.

1983 • 219 citations

TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATE

1985 • 196 citations

The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitors

1988 • 171 citations

STERILISATION OF HEPATITIS AND HTLV-III VIRUSES BY EXPOSURE TO TRI(n-BUTYL)PHOSPHATE AND SODIUM CHOLATE

1986 • 142 citations

Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies

1985 • 142 citations

Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.

1986 • 140 citations

Characterization of the human Factor VIII procoagulant protein with a heterologous precipitating antibody

1982 • 84 citations

Factor concentrates for treatment of hemophilia: which one to choose? [see comments]

1989 • 80 citations

ANTIBODIES TO HUMAN T CELL LEUKAEMIA VIRUS-ASSOCIATED MEMBRANE ANTIGENS IN HAEMOPHILIACS: EVIDENCE FOR INFECTION BEFORE 1980

1983 • 66 citations

A two-phase linear regression model for biologic half-life data.

1990 • 64 citations

Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationships and functional epitopes.

1985 • 61 citations

Comparison of antigen assay and reverse transcriptase assay for detecting human immunodeficiency virus in culture

1987 • 45 citations

Acquisition of Antibody to Lymphadenopathy-Associated Virus in Patients with Classic Hemophilia (Factor VIII Deficiency)

1985 • 44 citations

Antihemophilic factor [factor VIII] preparations inhibit lymphocyte proliferation and production of interleukin-2.

1986 • 40 citations

Radioimmunoassay for coagulant factor VIII-related antigen (VIII:CAg)

1979 • 38 citations

Acute Hepatitis Non-A, Non-B following Administration of Factor VIII Concentrates

1981 • 32 citations

Circulating Immune Complexes Pre and Post Clotting Factor Infusion in Hemophilia

1981 • 7 citations

Risk of transmission of human immunodeficiency virus (HIV) by heat‐ treated factor VIII concentrates in patients with severe hemophilia A

1987 • 5 citations

Hepatitis transmission by blood products

1988 • 4 citations